Atai Life Sciences (NasdaqGM:ATAI) Earnings Call Presentation

AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003 in Patients with Treatment-Resistant Depression November 10, 2025 Disclaimer The following disclaimer applies to this Presentation. For the purposes of this disclaimer, "Presentation" means this document, its contents or any part of it, any oral presentation, any question or answer session and any written or oral material discussed or distributed during the Presentation meeting. The purpose of this Presentati ...